Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

U0126-EtOH

🥰Excellent
Catalog No. T6223Cas No. 1173097-76-1
Alias U0126 Ethanol, U0126

U0126-etoh (U0126 Ethanol) is a non-ATP competitive inhibitor of MEK1 (IC50=72 nM) and MEK2 (IC50=58 nM) with selectivity. U0126-EtOH inhibited autophagy and mitophagy.

U0126-EtOH

U0126-EtOH

🥰Excellent
Purity: 99.88%
Catalog No. T6223Alias U0126 Ethanol, U0126Cas No. 1173097-76-1
U0126-etoh (U0126 Ethanol) is a non-ATP competitive inhibitor of MEK1 (IC50=72 nM) and MEK2 (IC50=58 nM) with selectivity. U0126-EtOH inhibited autophagy and mitophagy.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
5 mg$30In StockIn Stock
10 mg$47In StockIn Stock
25 mg$65In StockIn Stock
50 mg$78In StockIn Stock
100 mg$98In StockIn Stock
1 mL x 10 mM (in DMSO)$50In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.88%
Color:White to Yellow
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
U0126-etoh (U0126 Ethanol) is a non-ATP competitive inhibitor of MEK1 (IC50=72 nM) and MEK2 (IC50=58 nM) with selectivity. U0126-EtOH inhibited autophagy and mitophagy.
Targets&IC50
A549 cells (H1N1v):1.2 ± 0.4 μM (EC50), MEK1:70 nM (cell free), MDCKII cells (H1N1v):74.7 ± 1.0 μM (EC50), MEK2:60 nM (cell free)
In vitro
METHODS: The transcriptional activity of AP-1 in COS-7 cells was detected after treatment with U0126-EtOH.
RESULTS: U0126-EtOH inhibits AP-1 transcriptional activity (IC50=1 μM). [1]
METHODS: HCT116 cells were treated with U0126-EtOH and colony formation was detected by soft AGAR growth assay. HeLa cells were treated with U0126-EtOH and the ELK1-luciferase reporter gene was detected.
RESULTS: U0126-EtOH inhibited adheron-independent colony formation (IC50=19.4 μM), and U0126-EtOH inhibited EGF-stimulated Elk1 luciferase reporter gene (IC50=0.29 μM). [2]
METHODS: Mouse RAS-3T3 cells were treated with U0126-EtOH, and the phosphorylation level of ERK1/2 was detected by ELISA.
RESULTS: U0126-EtOH at a concentration of 10-40 μM inhibits MEK-mediated phosphorylation of ERK1/2. [3]
In vivo
METHODS: To study the anti-tumor activity of U0126-EtOH, U0126-EtOH (10.5 mg/kg) was intraperitoneally injected into mice every day for treatment.
RESULTS: U0126-EtOH led to a significant reduction in tumor implantation and early growth. The tumor volume decreased by 60-70% 9 days after injection and remained in this state thereafter. [4]
METHODS: To study the effect of U0126-EtOH on vascular constriction, rats received 120 minutes of temporary midcerebral artery occlusion (tMCAO), and then U0126-EtOH (30 mg/kg) was intraperitoneally injected into the rats.
RESULTS: After treatment with U0126-EtOH, the vasoconstriction of S6c was significantly reduced. [5]
Kinase Assay
The amount of immunoprecipitated wild type MEK used in these assays was adjusted to give a similar amount of activity units as obtained with 10 nM recombinant MEK. All other assays were performed with a recombinant, constitutively activated mutant MEK-1 (ΔN3-S218E/S222D) or constitutively active MEK-2(S222E/S226D). Reaction velocities were measured using a 96-well nitrocellulose filter apparatus as described below. Unless otherwise noted, reactions were carried out at an enzyme concentration of 10 nM, in 20 mM Hepes, 10 mM MgCl2, 5 mM β-mercaptoethanol, 0.1 mg/ml BSA, pH 7.4, at room temperature. Reactions were initiated by the addition of [γ-33P]ATP into the premixed MEK/ERK/inhibitor reaction mixture, and an aliquot of 100 μl was taken every 6 min and transferred to the 96-well nitrocellulose membrane plate which had 50 mM EDTA to stop the reaction. The membrane plate was drawn and washed 4 times with buffer under vacuum. Wells were then filled with 30 μl of Microscint-20 scintillation fluid, and the radioactivity of33P-phosphorylated ERK was counted with a Top Count scintillation counter. Velocities were obtained from the slopes of radioactivity versus time plots. Concentrations of ERK and ATP were 400 nM and 40 μM, respectively, unless otherwise indicated [2].
Cell Research
HEK293 cells were maintained in Dulbecco's modification of Eagle's medium (low glucose) plus 10% foetal bovine serum. HeLa cells stably expressing wild type or kinase-dead LKB1 have been described. AMPK activity was determined by immunoprecipitate kinase assays using anti-AMPK-a1 and -a2 antibodies. Antibodies recognising AMPK phosphorylated on Thr-172 (anti-pT172), AMPK-α1 and -α2 and acetyl-CoA carboxylase-1 (ACC1) phosphorylated on Ser-80 [16] were described previously. Quantification of ratios of signals from phosphorylated and total protein using these antibodies was performed by dual labelling using the LI-COR Odyssey IR imager as described. Contents of ATP and ADP were determined for cells in 6 cm culture dishes by quickly pouring off the medium, adding 350 μl of ice-cold 5% perchloric acid, scraping the cells off with a plastic scraper, and centrifuging (14 000 · g; 3 min, 4 °C) to remove insoluble material. The perchloric acid was then extracted from the supernatant and nucleotides analysed by capillary electrophoresis of perchloric acid extracts as described previously. All incubations of cells were performed in triplicate and results are expressed as means ± S.E.M [3].
Animal Research
Prior to injection, FI cells were labeled with a stable fluorescent dye molecule, DiA at 10 μg/ml for 5 h at 37 1C. After washing to remove free DiA, cells were trypsinized for inoculation (U0126 experiments) or transfection (RNAi experiments). Biliary epithelial cells were injected subcutaneously, at the indicated times, into the tibia of nude mice. In the chemical experiments, 3h after inoculation, mice were treated with U0126 (10.5 mg/kg) daily by intraperitoneal injection. The length and width of each tumor were measured every day by using a caliper. The following formula was used to calculate tumor volumes ? width2 length/2. Mice were killed at the end of experiment. Tumors were immediately frozen in liquid nitrogen [5].
SynonymsU0126 Ethanol, U0126
Chemical Properties
Molecular Weight426.6
FormulaC18H16N6S2·C2H6O
Cas No.1173097-76-1
SmilesCCO.N\C(Sc1ccccc1N)=C(\C#N)/C(/C#N)=C(\N)Sc1ccccc1N
Relative Density.no data available
Storage & Solubility Information
StorageIn solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
Ethanol: < 1 mg/mL (insoluble or slightly soluble)
DMSO: 255 mg/mL (597.75 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 7.9 mg/mL (18.52 mM), Solution.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.3441 mL11.7206 mL23.4412 mL117.2058 mL
5 mM0.4688 mL2.3441 mL4.6882 mL23.4412 mL
10 mM0.2344 mL1.1721 mL2.3441 mL11.7206 mL
20 mM0.1172 mL0.5860 mL1.1721 mL5.8603 mL
50 mM0.0469 mL0.2344 mL0.4688 mL2.3441 mL
100 mM0.0234 mL0.1172 mL0.2344 mL1.1721 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy U0126-EtOH | purchase U0126-EtOH | U0126-EtOH cost | order U0126-EtOH | U0126-EtOH chemical structure | U0126-EtOH in vivo | U0126-EtOH in vitro | U0126-EtOH formula | U0126-EtOH molecular weight